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Inflammation is defined as a defensive reaction involving
the immune system. However, chronic inflammation in-
duced by prolonged stresses, including infection, physio-
logical stress, or overnutrition, activates immune cells
and/or interstitial cells, causing tissue remodeling, which
plays a pivotal role in the pathogenesis of chronic in-
flammatory diseases. Chronic inflammation is associated
with atherosclerotic vascular diseases, heart failure,
metabolic syndrome, neurodegenerative diseases, cancer,
and others.
For example, Virchow had already reported that ath-
erosclerosis is an inflammatory disease in the nineteenth
century [1]. However, currently, only a few therapeutic
strategies targeting inflammation have evidence for ath-
erosclerosis prevention. The major medical science goal
is to develop effective, well-refined therapies. Accom-
plishing this task requires the continuation of research
and a comprehensive understanding of the pathophysi-
ology of these diseases. In this thematic series, Frontiers
of inflammatory disease research: Inflammation in car-
diovascular–cerebral diseases, in Inflammation and Re-
generation, three leading research teams at the forefront
of this field have provided their review articles to elabor-
ate on current research in this field.
Dr. Miyazaki and colleagues from Showa University
reviewed the current understanding of calpain-associated
regulation of endothelial cell (EC) functions [2]. EC func-
tion is important for vascular and systemic homeostasis.
Accumulating evidence suggests that dysfunction in intra-
cellular proteolytic systems disturbs EC adaptation to the
inflammatory environment, leading to the development of
vascular disorders (e.g., atherosclerosis and pathological
angiogenesis). Moreover, Dr. Miyazaki and colleagues
discussed recent findings, including their own, on the
contribution of calpain–calpastatin-mediated regulation of
EC functions.
In the research performed at Tokushima University,
Dr. Nishimoto and colleagues reviewed current know-
ledge associated with sterile inflammation caused by
Toll-like receptor (TLR) 9 and its endogenous ligands
in the development of cardiometabolic diseases [3].
Lifestyle-related diseases, such as hyperlipidemia, partici-
pate in the pathogenesis of cardiometabolic disorders.
However, the underlying mechanisms remain obscure. Dr.
Nishimoto and colleagues discussed recent findings, in-
cluding their own, and suggested that sterile inflammation
modulated by TLR9 links lifestyle-related diseases to
chronic inflammation in cardiometabolic organs.
Increasing evidence suggests the contribution of
chronic inflammation to the pathogenesis of neurode-
generative diseases. Drs. Otani and Shichita from Tokyo
Metropolitan Institute of Medical Science summarized
recent evidence regarding sterile immune responses in neu-
rodegenerative diseases [4]. Dr. Otani discussed the mecha-
nisms by which sterile inflammation is activated in the
central nervous system and introduced recent advances in
understanding molecular mechanisms associated with ster-
ile inflammation in several neurodegenerative diseases. Fur-
thermore, an understanding of the detailed molecular and
cellular mechanisms in each neurodegenerative disease is
necessary for the development of therapeutic strategies.
Sincere gratitude is expressed to the distinguished re-
searchers for their contribution to this thematic series
reviews with the hope that these review articles will pro-
vide novel insights for the understanding of the mechan-
ism and the development of new therapeutic strategies
for cardiovascular–cerebral inflammatory diseases.
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